key: cord-0928019-llbkd453
authors: Loney, Tom; Khansaheb, Hamda; Ramaswamy, Sathishkumar; Harilal, Divinlal; Deesi, Zulfa Omar; Varghese, Rupa Murthy; Belal Al Ali, Aydah; Khadeeja, Anees; Al Suwaidi, Hanan; Alkhajeh, Abdulmajeed; Mohamed AlDabal, Laila; Uddin, Mohammed; Al Faresi, Mubarak; Joshi, Madhvi; Senok, Abiola; Nowotny, Norbert; Alsheikh‐Ali, Alawi; Abou Tayoun, Ahmad
title: Genotype‐phenotype correlation identified a novel SARS‐CoV‐2 variant possibly linked to severe disease
date: 2021-02-21
journal: Transbound Emerg Dis
DOI: 10.1111/tbed.14004
sha: b200ceaa8e42a04ffd24e6b6ada129cfac8636be
doc_id: 928019
cord_uid: llbkd453

The geographic location and heterogeneous multi‐ethnic population of Dubai (United Arab Emirates; UAE) provide a unique setting to explore the global molecular epidemiology of SARS‐CoV‐2 and relationship between different viral strains and disease severity. We systematically selected (i.e. every 100th individual in the central Dubai COVID‐19 database) 256 patients by age, sex, disease severity and month to provide a representative sample of laboratory‐confirmed COVID‐19 patients (nasopharyngeal swab PCR positive) during the first wave of the UAE outbreak (January to June 2020). Sociodemographic and clinical data were extracted from medical records and full SARS‐CoV‐2 genome sequences extracted from nasopharyngeal swabs were analysed. Older age was significantly associated with COVID‐19‐associated hospital admission and mortality. Overweight/obese or diabetic patients were 3–4 times more likely to be admitted to hospital and intensive care unit (ICU). Sequencing data showed multiple independent viral introductions into the UAE from Europe, Iran and Asia (29 January–18 March), and these early strains seeded significant clustering consistent with almost exclusive community‐based transmission between April and June 2020. Majority of sequenced strains (N = 60, 52%) were from the European cluster consistent with the higher infectivity rates associated with the D614G mutation carried by most strains in this cluster. A total of 986 mutations were identified in 115 genomes, 272 were unique (majority were missense, n = 134) and 20/272 mutations were novel. A missense (Q271R) and synonymous (R41R) mutation in the S and N proteins, respectively, were identified in 2/27 patients with severe COVID‐19 but not in patients with mild or moderate disease (0/86; p = .05, Fisher's Exact Test). Both patients were women (51–64 years) with no significant underlying health conditions. The same two mutations were identified in a healthy 37‐year‐old Indian man who was hospitalized in India due to COVID‐19. Our findings provide evidence for continued community‐based transmission of the European strains in the Dubai population and highlight new mutations that might be associated with severe disease in otherwise healthy adults.

Since December 2019, the emergence of a novel virus later named SARS-CoV-2 causing respiratory disease (called COVID-19) has spread to 192 countries and infected more than 102 million people causing 2.2 million deaths (Johns Hopkins Center for Systems Sciences & Engineering, 2020; Uddin et al., 2020) . All countries have upscaled their testing capabilities to identify infected individuals for isolation and contact tracing using the gold-standard reverse transcriptase quantitative PCR (RT-qPCR) to detect SARS-CoV-2 RNA in the nasopharyngeal swabs of suspected cases . However, RT-qPCR cannot be used to determine which viral strains are circulating in the population, or the relationship between viral strain and disease severity. As such, it is vital for public health policy decisions to know the origin of, and predominant viral strains circulating in a population, and the association between these viral strains and clinical outcomes . SARS-CoV-2 whole genome sequencing (cWGS) can be used to delineate the geographic origins and evolution of a virus through phylogenetic analysis (Butler et al., 2020; Tayoun et al., 2020) in combination with large volumes of viral sequence data accumulated from all over the world (Hadfield et al., 2018) .

Previous genetic sequencing and phylogenetic sequencing studies have shown the introduction, transmission and evolution of the virus within and between countries (Alm et al., 2020; Jesus et al., 2020; Stefanelli et al., 2020; Yang et al., 2020) . However, these studies have been limited by the recruitment of opportunistic and convenient samples and lacked the clinical data that is required to explore the association between viral strain and disease severity.

In the United Arab Emirates (UAE), Dubai is a cosmopolitan city that has the busiest airport in the world connecting the east with the west and has quickly become a popular tourist destination for travellers Uddin et al., 2020) . Moreover, Dubai is a global centre for trade, finance and healthcare attracting a diverse multi-ethnic population from countries all over the world (Loney et al., 2013) . Indeed, our earlier work on the index and early UAE cases showed multiple spatio-temporal viral introductions into the UAE from tourists and residents travelling from Asia, Europe and the Middle East . Dubai's geographic location and unique heterogeneous population make it an ideal setting to explore the global molecular epidemiology of SARS-CoV-2 and the relationship between viral strain and disease severity. In this study, we utilize a representative sample of patients with COVID-19 from the Dubai population to explore the relationship between various sociodemographic, clinical and viral genomic factors and disease severity.

The Dubai Scientific Research Ethics Committee-Dubai Health Authority (approval number #DSREC-04/2020_02) approved this study. All patients treated at a healthcare facility in the UAE provide written consent for their de-identified data to be used for research, and this study was performed in accordance with the relevant laws and regulations that govern research in the UAE. As this study was part of a public health surveillance and outbreak investigation in the UAE, the requirement for informed consent, specifically for this study, was waived by the Research Ethics Committee.

Sociodemographic and clinical data were extracted from the electronic medical records of 256 patients with laboratory-confirmed SARS-CoV-2 (nasopharyngeal swab PCR positive) from 29 January to 30 June 2020 using the WHO case report form. In order to provide a representative sample, participants were systematically selected from a database containing the details for all cases in Dubai during the study time period stratified by age (<40 years, ≥40 years), sex (male, female), disease severity (asymptomatic/mild, moderate, severe/critical) and stage of the pandemic (<01 April, ≥01 April 

All 256 COVID-19 patients tested positive for SARS-CoV-2 by RT-qPCR on RNA extracted from nasopharyngeal swabs using the QIAamp Viral RNA Mini or the EZ1 DSP Virus Kits (Qiagen). SARS-CoV-2 whole genome sequencing was performed using either shotgun transcriptome sequencing (Jain et al., 2021; Tayoun et al., 2020) or viral target enrichment and deep sequencing Kit (Qiagen) and then amplified using 26 overlapping primer sets covering most of the SARS-CoV-2 genome as recently described by our group . PCR products were then fragmented by ultra-sonication (Covaris LE220-plus series) and prepared for sequencing using the SureSelectXT Library Preparation kit (Agilent). The target enrichment libraries were sequenced using the Illumina MiSeq Reagent Kit V2 (2 X 150 cycles) or the NovaSeq SP Reagent kit (2 × 150 cycles).

The adapter sequences were trimmed using BCL2fastq v.2.20.0, and then, high-quality sequencing reads were aligned to the reference SARS-CoV-2 genome from Wuhan, China (GenBank accession number: NC_045512.2) using BWA v0.7.17. Consensus sequences were generated using GATK v3.8-1-0 and BCFtools v1.3.1 for samples

where > 80% of nucleotide positions (56-29,797) had at least 10X coverage. A total of 115 UAE isolates met this coverage criterion (Table S1) and were submitted to the Global Initiative on Sharing All Influenza Data (GISAID) database under accession numbers listed in Table S2 .

Multiple sequence alignment of UAE SARS-CoV-2 isolates (n = 115) was performed using MAFT v7.455 (Katoh et al., 2002) and phylogenetic tree was built using IQtree v1.6.12 with a bootstrap of 1,000 replicates (Chernomor et al., 2016) . In addition, the evolutionary time scale was estimated by using BEAST v.1.10.4 (Suchard et al., 2018) with strict clock mode. The Hasegawa-Kishino-Yano substitution model was used with 4 rate categories drawn from a gamma distribution (GTR4G).

Finally, we estimated the mutation rate from the resulting BEAST tree.

The final tree was visualized by Figtree v1.4.4 (Rambaut, 2018). 

We obtained the nasopharyngeal swabs and data regarding the soci- and chest pain (46.8%) were significantly more common symptoms amongst patients with moderate disease, and a sore throat (17.2%) had a significantly higher prevalence amongst asymptomatic/mild cases (Table 2) .

Mean temperature, heart rate, respiratory rate and systolic blood pressure were significantly higher and mean oxygen saturation significantly lower in the severe/critical disease category. Nearly, half of all patients required oxygen therapy and the mortality ratio was 30.0% in the patients with severe disease (Table 2) .

Univariate and multivariate logistic regression for factors associated with, COVID-related hospital admissions, intensive care unit admission and COVID-associated mortality (N = 256) 

Age was significantly associated with COVID-19-related hospital admission and COVID-19-associated mortality but not ICU admission, with patients aged 40 years and older twice as likely to be admitted to hospital compared with younger patients (Table 3) . Compared with patients of European descent, patients from the Middle East and Africa, South Asia and East Asia regions were 12-13 times more likely to be admitted to hospital, but there was no association with ICU admission or mortality (Table 3) . Overweight and obese patients (BMI ≥ 25.0 kg/m 2 ) were 3-4 times more likely to be admitted to hospital and ICU compared with healthy weight patients, and patients with diabetes mellitus were three times more likely to be admitted to ICU compared with patients without diabetes (Table 3 ). Patients that were more likely to have been infected from community transmission as opposed to imported infections were four times more likely to be admitted to hospital with either moderate or severe/critical disease (Table 3 ).

SARS-CoV-2 whole genome sequencing was performed using RNA extracted from nasopharyngeal samples of all 256 COVID-19 patients (Methods). A total of 115 genomes meeting our coverage criteria were assembled and used for phylogenetic analysis, mutational analysis and genotype-phenotype correlation. Overall, we were able to assemble full genomes from 115 patients with an average coverage of 890X where more than 97% of the SARS-CoV-2 genome had at least 10X coverage (Figure 1 ).

Of the sequenced genomes, 30 were obtained by shotgun transcriptome sequencing where, on average, 3% of the reads mapped to the SARS-CoV-2 genome with an average coverage of 1,756X

and > 99% of the virus genome having at least 10X reads (Table S1 ).

On the other hand, 85 full genomes were obtained by target enrichment followed by sequencing. On average, 96% of the reads mapped to the SARS-CoV-2 genome using this protocol with an average coverage of 582X where > 96% of the genome had ≥ 10X reads (Table S1 ).

In aggregate, a total of 272 unique mutations were identified in all 115 genomes relative to the reference SARS-CoV-2 Wuhan genome (GenBank Accession: NC_045512.2) (Figure 1 ) with an average of 8.6

(1-17) mutations per genome. Some mutations were more frequent than others; for example, the 241C>T, 3037C>T, 14408C>T, and the 23403A>G (also known as the D614G mutation in the S protein), were each seen in 58 of the genomes (Table S3) in the S protein (Table S3 ). The majority of the sequenced strains (N = 60, 52%) were in the European cluster, while 30% (N = 34) and 18% (N = 21) were in the Asian and Iranian clusters, respectively (Figure 3 ). The predominance of European cluster is consistent with the higher infectivity rates associated with the D614G mutation carried by most strains in this cluster ( Figure S1 ).

The assembled 115 genomes were obtained from patients with mild (N = 54), moderate (N = 32) and severe (N = 27) disease, while clinical information was not available for two patients. The majority were males (N = 77, 67%) and the mean age was 41 years though age was highest in the severe disease group (50 years) (Table S4) .

To determine if any viral mutation was associated with severe 

Our study is the first in the Middle East region to explore the association between sociodemographic factors, SARS-CoV-2 viral strains and clinical outcomes in a representative sample of patients with COVID-19 in Dubai. Similar to other studies from around the world, age and underlying health conditions were positively associated with COVID-19-related hospital admission. Patients ≥ 40 years were twice as likely to be admitted to hospital compared with younger patients and overweight/obese or diabetic patients were 3-4 times more likely to be admitted to hospital and ICU.

Using two different sequencing protocols, we successfully obtained 115 full SARS-CoV-2 genomes from a representative patient sample in Dubai. Our analysis showed that 20 out of the 272 unique viral sequence variants identified in this cohort were novel. This data, which was submitted to GISAID, contributes to the growing variation catalogue of this novel virus and further delineates its mutational landscape.

Our phylogenetic analysis showed that multiple early introductions of SARS-CoV-2 into the UAE during the earlier phase of the pandemic (January -March 2020) (Alm et al., 2020; Harilal et al., 2020; Tayoun et al., 2020 ) seeded significant clustering due to community-based transmission subsequently between April and June 2020. This clustering overlapped with the closure of Dubai

International Airport on March 25, 2020, further supporting the community-based mode of transmission. The three major clusters were an extension of the early European, Asian and Iranian strains , though strains of European origin constitute the majority (60/115). Most of those strains (58/60) carried the D614G mutation previously associated with higher infectivity rates (Volz et al., 2020; Zhang et al., 2020) . Thus, the closure of international flights and the strict community-based transmission between April -June 2020 in the UAE provides another epidemiological evidence that the D614G mutation increases infectivity (16, 17) ( Figure S1 ).

Our genotype-phenotype analysis suggests a possible association between the Q271R missense and R41R synonymous mutations in the S and N genes, respectively, and disease severity.

Those two mutations were very rare suggesting a strong negative selective pressure. They were simultaneously identified in only 4 patients (2 in our cohort and 2 in GISAID EPI_ISL_426414 and EPI_ ISL_698928), 3 of whom did not have high risk of developing severe disease outcomes (i.e. were either young or females without 

Authors have no conflicts of interest to disclose.

AAA, AAT, NN and TL conceived the study and drafted the protocol. All authors provided critical input into the protocol. AAA, AAK and HK coordinated the ethical approval and sample retrieval. RV, ZD, ABA and AK conducted the RT-qPCR analysis. AAT, SR and DH performed the whole genome sequencing and phylogenetic analysis. HK performed data extraction from the medical records and TL completed data analysis for the manuscript. AAT and TL drafted the manuscript, AAA and NN refined it before all authors provided comments and feedback on the first draft, and then read and approved the final version of the manuscript.

All data generated or analysed during this study are included in this published article (and its Supplementary Information files) , and the F I G U R E 4 Association of SARS-CoV-2 sequence variants with COVID-19 clinical severity. X-axis indicates SARS-CoV2 genomic locus/ mutation and Y-axis indicates the percentage of patients with severe (red circles) and mild/moderate (blue circles) disease at each mutation. Two mutations, Q271R and R41R in the S and N genes, respectively, were found in severely sick patients only (p = .055, two tailed t-test) sequences are available on the GISAID database under the corresponding accession numbers. 

WHO European Region sequencing laboratories and GISAID EpiCoV group; WHO European Region sequencing laboratories and GISAID EpiCoV group* (2020). Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region

Shotgun transcriptome and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions

Terrace aware data structure for phylogenomic inference from supermatrices

Nextstrain: Realtime tracking of pathogen evolution

SARS-CoV-2 whole genome amplification and sequencing for effective population-based surveillance and control of viral transmission

Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes

Importation and early local transmission of COVID-19 in Brazil

COVID-19 Dashboard

MAFFT: A novel method for rapid multiple sequence alignment based on fast Fourier transform

An analysis of the health status of the United Arab Emirates: The 'Big 4' public health issues

FigTree 1.4.2 software

Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in

Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evolution, 4, vey016

Multiple early introductions of SARS-CoV-2 into a global travel hub in the Middle East

SARS-CoV-2/COVID-19: Viral genomics, epidemiology, vaccines, and therapeutic interventions

Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity

Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries

SARS-CoV-2 spikeprotein D614G mutation increases virion spike density and infectivity

Genotype-phenotype correlation identified a novel SARS-CoV-2 variant possibly linked to severe disease